Public Profile

Akeso

Akeso, Inc., a leading biopharmaceutical company headquartered in China (CN), is renowned for its innovative approach in the fields of oncology and autoimmune diseases. Founded in 2007, Akeso has rapidly established itself as a key player in the biopharma industry, with a strong focus on the research, development, and commercialisation of monoclonal antibodies and bispecific antibodies. With major operational regions across Asia and expanding into global markets, Akeso's core products include its proprietary therapies that target various cancers and immune disorders. The company is distinguished by its commitment to advancing biologics, leveraging cutting-edge technology to enhance treatment efficacy. Notably, Akeso has achieved significant milestones, including successful clinical trials and partnerships that bolster its market position, making it a formidable contender in the competitive biopharmaceutical landscape.

DitchCarbon Score

How does Akeso's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

23

Industry Benchmark

Akeso's score of 26 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

77%

Let us know if this data was useful to you

Akeso's reported carbon emissions

In 2023, Akeso reported total carbon emissions of approximately 28,229,430 kg CO2e, with Scope 1 emissions at about 1,397,580 kg CO2e and Scope 2 emissions at approximately 26,831,850 kg CO2e. This marks an increase from 2022, when total emissions were about 23,740,020 kg CO2e, with Scope 1 emissions of approximately 82,000 kg CO2e and Scope 2 emissions of around 23,658,020 kg CO2e. Over the past few years, Akeso has demonstrated a commitment to monitoring and reporting its emissions, focusing on Scope 1 and Scope 2, while not disclosing any Scope 3 emissions data. In 2021, the company reported total emissions of about 4,530,880 kg CO2e, with Scope 1 at approximately 35,230 kg CO2e and Scope 2 at around 4,495,650 kg CO2e. In 2020, emissions were about 4,174,020 kg CO2e, with Scope 1 at approximately 44,390 kg CO2e and Scope 2 at around 4,129,630 kg CO2e. Despite the increase in emissions in 2023, Akeso has not set specific reduction targets or initiatives as part of its climate commitments. The company continues to engage in emissions tracking, which is essential for future climate action and sustainability efforts.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2020202120222023
Scope 1
44,390
00,000
00,000
0,000,000
Scope 2
4,129,630
0,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Akeso's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Akeso is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Akeso is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Hengrui Pharma

CN
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Bms

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Beigene

CN
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 days ago

Shanghai Henlius Biotech

CN
Research and development services (73)
Updated 24 days ago

Merck And Co

US
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Junshi Biosciences

CN
Chemicals nec
Updated 24 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers